Login   |   Register

Submissions

Online Submissions

Already have a Username/Password for Reumatismo?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

To submit a paper to our journal:

  1. Register as an Author; we encourage you to register also as a reader and a reviewer at the same time.
  2. Follows the Instructions to authors below.
  3. Read our Editorial Policies and our Competing Interest policies

To submit a revised version:

  1. Log in
  2. Click on your role as Author
  3. Click on QUEUED FOR REVIEW on the page displayed
  4. Under the heading EDITOR DECISION, upload your revised paper as AUTHOR VERSION using Browse and Upload buttons
  5. Use the NOTIFY EDITOR email to inform editors that the revised version has been submitted

 

Advice to contributors

All manuscripts must be submitted online through www.reumatismo.org

The Journal publishes Original Articles on clinical or experimental research, Case Reports, Short Reports, Letters to the Editor, Editorials and Reviews.

Original Articles should concern rheumatology as well as other subjects not strictly related to rheumatology, but of interest to a rheumatological readership; they must concern material never published before (in part or in full). Requirements: Original Articles must not exceed 3500 words excluding references, tables and figure legends.  The total number of figures or tables should not exceed 6.

Case reports and Short reports should describe a condition whose characteristics may provide a contribution of general interest. Requirements: Case and Short Reports must not be longer than 1800 words, figures, tables and references excluded. 15 references or less and a maximum of 2 figures or tables are allowed.

Letters to the Editor will refer to works already published on the Journal or to topics regarded as interesting. Requirements: Letters to the Editor must not exceed 800 words, references included.

Editorials on selected subjects are accepted only on demand. Requirements: Editorials should be limited within 1.000 words with maximum 20 references.

Reviews will deal with current problems of major interests; they should not exceed 4000 words and 5 among tables and figures. Reumatismo publishes also monographic issues composed only of reviews that are commissioned to authors.

As a rule, manuscripts should be divided into the following parts: a) title; b) summary; c) introduction, which should present the subject and explain the aims of the work with references to the most up-to-date literature; d) materials and methods, which should inform with precision about the materials (clinical series, etc.) investigated and which should describe the methods employed by the authors; e) results; f) discussion, which should include the authors' conclusions; g) references; h) acknowledgments.
The same order should be observed also in the Italian-written manuscript.

Manuscripts must be accompanied by a cover letter indicating the type of article and including the statement that the article has not been published previously nor submitted elsewhere. 
Articles express the authors' opinion and do not commit the Journal.

Instructions for the drafting of manuscripts

Reumatismo is a bilingual journal (Italian and English); manuscripts must be written in English and submitted together with the Italian translation. Authors whose native language is not Italian will have their manuscript translated in-house for the printed version of the Journal.

Authors whose native language is not English are strongly advised to have their manuscript checked by a language editing service, or by an English mother-tongue colleague prior to submission.
As an option, PAGEPress offers its own professional copyediting service. Professional copyediting can help authors improve the presentation of their work and increase its chances of being accepted by a publisher. In case you feel that your manuscript needs a professional English language copyediting checking language grammar and style, PAGEPress offers a chargeable revision service in a few days. Please contact us to get more detailed information on this service.

Manuscripts must be prepared with a standard word processor (preferably Microsoft Word or OpenOffice). Pages should be in A4 format and numbered. Times New Roman 12 pt is the advised font. Lines should be left numbered in continuum, to make the referees’ work easier, double-spaced and without interruption of page. Every page of the manuscript must be numbered.
Manuscripts with single spacing and/or with excessive corrections will be rejected.

The first page should include: a) a running title; b) authors' complete names; c) Institution(s) where the work was done; d) a list of 3-5 key words; e) first name and surname, mailing address, telephone, fax numbers as well as email address of the corresponding Author.
The summary in Italian must be no more than 100 words long and will explain briefly the aim of the work, what was done and the conclusion.
The summary must be on the second page and be no more than 250 words long, including the following sections: Objective, Methods, Results, Conclusions.
References should include all of the references reported in the text and be compiled numerically according to the order of citation. The surname of every author should be quoted; when there are more than six authors, the first six names should be followed by "et al.". The remaining of the references should be ordered as follows: title of the article, name of the journal abbreviated in accordance with the style of Index Medicus, year, volume number, first and last page numbers, the latter properly abbreviated (e.g., 1023-5 or 1023-31). Italics, boldface and underlining should not be used, as well as capitalization of entire words. For punctuation, editorials, letters, journal supplements and abstracts, authors should refer to the reported examples. Unusual references should be conformed to the styles that can be found in the article "The Vancouver Group. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. JAMA 1993; 269; 2282-6".

References to medical periods

  • Standard article
    Maddison PJ, Lee L, Reichlin M, Sinclair A, Wasson C, Schemmer G. Anti p-57. A novel association with neonatal lupus. Clin Exp Immunol 1995; 99: 42-8.
  • Article in volume supplement
    Magni F, Rossoni G, Berti F. BN-52021 protects guinea pig from heart anaphylaxis. Pharmacol Res Commun 1988; Suppl. 5: 75-8.
  • Article in number supplement
    Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore P. The natural history of tardive dyskinesia. J Clin Psychopharmacol 1988; 8 (4 Suppl): 31S-37S.

References to books and monographs

  • With one or more authors
    Colson JH, Armour WJ. Sports injuries and their treatment. 2nd rev. ed. London: S. Paul, 1986.
  • With Editor/s
    McCarty DJ, Koopman WJ. Arthritis and allied conditions. A textbook of rheumatology. 12th ed Philadelphia, London: Lea and Fabiger, 1993.
  • Chapter in a book
    Sledge CB. Biology of the joint. In: Kelley WN, Harris ED jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology, 3rd ed. Philadelphia: Saunders, 1989: 1-21.
  • Proceedings
    Vivan CL, ed. Child abuse and neglet. A medical community response. Proceedings of the First AMA National Conference on Child Abuse and Neglet; 1984 Mar 30-31; Chicago, Chicago: American Medical Association, 1985.

References in the text should be given as number in brackets; Authors cited in the text should have their names entirely quoted if they are one or two; if they are more than two, only the first one should be mentioned, followed by et al.; in such cases the surname, or the two surnames, or et al. should be followed by the relative reference number. Authors are responsible for the accuracy of their references.

Tables should be clear, consistent and necessary for the understanding of the manuscripts. Every table, marked with Roman numerals, should be cited in the text and have a short title; furthermore, its placing in the text should be specified. Figures, accompanied by a short heading, should be marked with Arabic numerals and have a precise indication about their orientation and placing in the text. Tables and figures should carry the title of the manuscripts as well as the relative number on the back. To ensure a clear reproduction of the figures, photocopies are not accepted; photographs and/or slides should be technically perfect. Authors should consider the effect of possible reduction in size of photographs.

Acknowledgments should be placed altogether at the end of the manuscripts, and begin with "The Authors acknowledge".

Disclosures. Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly.
Kindly note that the forms should be completed and signed by each author of the work. We wait for the completed form to proceed with publication.
Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.

 

Manuscript acceptance

Manuscripts are accepted for publication according to their scientific interest and their relevance to a Rheumatological journal. They are accepted on unquestionable Editor's opinion supported by a written evaluation by at least two anonymous referees.

Manuscripts that require revisions are returned by the journal to the corresponding author for improvement.
The revised manuscript, edited in .DOC format, should be resubmitted electronically to the Editor-in-Chief (on reumatismo.org) within 8 weeks from the date of receipt by the author. If the revised manuscript is returned to the journal after the allotted time, it will be considered a new submission.

Peer-review policy

All manuscripts submitted to our journal are critically assessed by external and/or inhouse experts in accordance with the principles of Peer Review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely inhouse and has two major objectives: a) to establish the article's appropriateness for our journals' readership; b) to define the manuscript's priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than that it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer-review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare).
Authorship. All persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/sponsor.htm) Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based only on substantial contributions to (a) conception and design, or analysis and interpretation of data; and to (b) drafting the article or revising it critically for important intellectual content; and on (c) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.

Obligation to Register Clinical Trials
(
http://www.icmje.org). The ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, and the like. Our journals requires, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (
http://www.icmje.org/#clin_trials). For instance, ClinicalTrials.gov (www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.
Protection of Human Subjects and Animals in Research
. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, (as revised in 2008). In particular, PAGEPress adopts the WAME policy on Ethics in Research (http://www.wame.org). Documented review and approval from a formally constituted review board (Institutional Review Board - IRB - or Ethics committee) is required for all studies (prospective or retrospective) involving people, medical records, and human tissues. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is before another journal for consideration (or an explanation has been provided in the field "Comments to the Editor").
  2. The submission file is in Microsoft Word file format.
  3. The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed at the end of the manuscript.
  4. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in "About the Journal".
  5. Competing interest disclosure form(s) is (are) included.
 

Copyright Notice

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

 

Privacy Statement

Privacy is an important concern for users of our site and is something that PAGEPress takes very seriously. Below you will find our policy for protecting users' personal information. Registration on our website is optional and voluntary. Browsing and viewing articles on our website does not require any personal information to be submitted from users. Nor do these functions require the user's browser to be set to accept cookies. Some other services published on our website do require the use of cookies and information such as name, e-mail, etc. This is necessary for security reasons and to enable us to be able to assure standards of scientific integrity. Users may submit further personal information (e.g. details of research areas of interest) in order to take advantage of present and future personalization facilities on our website. In accordance with European Union guidelines, registrants may decline to provide the information requested. They should be advised, however, that PAGEPress may be unable to deliver its services unless at least the information necessary for security and identification purposes is provided. In order to offer the best possible service to users, PAGE Press tracks the patterns of usage of pages on the site. This enables us to identify the most popular articles and services. Where users have provided details of their research areas of interest, this information can be linked to them, helping PAGEPress to offer scientists, the most relevant information based on their areas of interest. User information will only be shared with third parties with the explicit consent of the user. Publishing a scientific manuscript is inherently a public (as opposed to anonymous) process. The name and e-mail address of all authors of a PAGEPress manuscript will be available to users of PAGEPress. These details are made available in this way purely to facilitate scientific communication. Collecting these e-mail addresses for commercial use is not allowed, nor will PAGEPress itself send unsolicited e-mails to authors, unless it directly concerns the paper they have published on PAGEPress journals. PAGEPress reserves the right to disclose members' personal information if required to do so by law, or in the good faith and belief that such action is reasonably necessary to comply with a legal process, respond to claims, or protect the rights, property or safety of PAGEPress, employees or members.

 


 

Reumatismo [eISSN 2240-2683] is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Available In Medline, Embase, and other online databases. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2014     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185